Literature DB >> 11464857

Retinoblastoma family proteins induce differentiation and regulate B-myb expression in neuroblastoma cells.

G Raschellà1, B Tanno, F Bonetto, A Negroni, R Amendola, M G Paggi.   

Abstract

BACKGROUND: The expression of several genes is modulated during neuroblastoma differentiation. The retinoblastoma family proteins, pRb, p107 and pRb2/p130, act in the repression of proliferation genes, interacting mainly with the E2F transcription factors. PROCEDURE AND
RESULTS: In this study, we found that, in neuroblastoma cell lines, pRb and p107 proteins decreased, undergoing progressive dephosphorylation, whereas pRb2/p130 increased at late stages of differentiation. B-myb expression was down-regulated in association with the up-regulation of pRb2/p130, the major partner of E2F on the E2F site of the B-myb promoter in differentiated cells. Transfection of each of the retinoblastoma family genes in neuroblastoma cells was able to induce neural differentiation, to inhibit 3H-thymidine incorporation, and to down-regulate B-myb promoter activity.
CONCLUSIONS: In conclusion, our data suggest a major contribution of retinoblastoma proteins, and especially of pRb2/p130, in B-myb promoter regulation and demonstrate the induction of neural differentiation by p107 and pRb2/p130, suggesting a role of these proteins in triggering differentiation-specific genes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11464857     DOI: 10.1002/1096-911X(20010101)36:1<104::AID-MPO1024>3.0.CO;2-9

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  1 in total

1.  Clonal evidence for the development of neuroblastoma with extensive copy-neutral loss of heterozygosity arising in a mature teratoma.

Authors:  Rintaro Ono; Hiroo Ueno; Kenichi Yoshida; Satoko Takahashi; Hiroki Yoshihara; Taiki Nozaki; Koyu Suzuki; Atsuko Nakazawa; Ryunosuke Saiki; Masafumi Seki; Junko Takita; Seishi Ogawa; Atsushi Manabe; Daisuke Hasegawa
Journal:  Cancer Sci       Date:  2021-05-06       Impact factor: 6.716

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.